FDA Panel Votes to Yank Preterm Birth Drug Off Market
Health
FDA Panel Votes to Yank Preterm Birth Drug Off Market
2022-10-19 20:17:07
by Dan McCue

WASHINGTON — An advisory panel to the Food and Drug Administration voted Wednesday to recommend that a drug intended to prevent women from having preterm births be removed from the market. Makena, manufactured by Covis Pharma, is the only approved... Read More

Straight From The Well
scroll top